Order Article Reprints

Maurer MM, Ibach M, Plewe J, Winter A, Ritschl P, Globke B, Öllinger R, Lurje G, Schöning W, Pratschke J, et al. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines. 2022; 10(2):272. https://doi.org/10.3390/biomedicines10020272

Maurer, Max M., Marius Ibach, Julius Plewe, Axel Winter, Paul Ritschl, Brigitta Globke, Robert Öllinger, Georg Lurje, Wenzel Schöning, Johann Pratschke, and et al. 2022. "Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients" Biomedicines 10, no. 2: 272. https://doi.org/10.3390/biomedicines10020272

Maurer, M. M., Ibach, M., Plewe, J., Winter, A., Ritschl, P., Globke, B., Öllinger, R., Lurje, G., Schöning, W., Pratschke, J., & Eurich, D. (2022). Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines, 10(2), 272. https://doi.org/10.3390/biomedicines10020272